Sitryx Therapeutics has a team of energetic and dedicated scientists, building a broad pipeline of novel agents targeting immunometabolic pathways to resolve disease.
We are currently seeking In Licensing opportunities to complement our pipeline, including assets that span the Hit to Candidate stages of drug development.
For further information and enquiries please contact: BusDev@Sitryx.com